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Abstract
Prolonged demands on the attention system can cause a decay in performance over time known as the time-on-task effect.
The inter-subject differences in the rate of this decline are large, and recent efforts have been made to understand the
biological bases of these individual differences. In this study, we investigate the genetic correlates of the time-on-task effect,
as well as its accompanying changes in subjective fatigue and mood. N=332 subjects performed a 20-minute test of
sustained attention (the Psychomotor Vigilance Test) and rated their subjective states before and after the test. We
observed substantial time-on-task effects on average, and large inter-individual differences in the rate of these declines. The
10-repeat allele of the variable number of tandem repeats marker (VNTR) in the dopamine transporter gene and the Met
allele of the catechol-o-methyl transferase (COMT) Val158Met polymorphism were associated with greater vulnerability to
time-on-task. Separately, the exon III DRD4 48 bp VNTR of the dopamine receptor gene DRD4 was associated with
subjective decreases in energy. No polymorphisms were associated with task-induced changes in mood. We posit that the
dopamine transporter and COMT genes exert their effects by increasing dopaminergic tone, which may induce long-term
changes in the prefrontal cortex, an important mediator of sustained attention. Thus, these alleles may affect performance
particularly when sustained dopamine release is necessary.
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Introduction
Sustaining attention for a length of time is a prerequisite for
performing many cognitive tasks. Failure to do so typically results in a
vigilance decrement, or time-on-task (TOT) effect [1,2], in which
accuracy and/or reaction times degrade over the period of
performance. This degradation is thought to be due to a weakening
of top-down control due to high demands on neural resources [3,4] as
well as increased boredom and distractibility [5], in particular due to
negative emotional stimuli [6,7]. Lapses owing to fatigue and the TOT
effect underlie many on-the-job errors that may in turn have serious
real-world consequences [8,9], thus providing the impetus to better
characterize and understand the biological basis of this phenomenon.
Recently, investigators have observed that there is substantial
inter-individual variability in the rate of TOT decline, with the
most resilient subjects showing almost no decrement over a
20–30 minute period [10,11]. It has been suggested that such
resilience is trait-like, and that biomarkers may exist that
differentiate resistant from vulnerable individuals. Indeed, a recent
study by Lim et al., (2010) demonstrated that between subjects,
resting-state cerebral blood flow in thalamus and middle frontal
cortex is predictive of subsequent TOT decrements [11].
The existence of such biomarkers supports the hypothesis that
time-on-task effects arise because resources in the brain are finite,
and must be economically deployed during times of high
attentional demand. If this is the case, individual differences in
TOT vulnerability may be determined either by resource
availability, or the ability of the neural system to tap into this
reservoir. It has been proposed that dopamine (DA) may be one of
the resources in question [10,12]. To date, support for dopamine
as being important to sustained attention has come largely from
the literature on attention-deficit hyperactivity disorder (ADHD).
ADHD is associated with prefrontal dysfunction [13,14], and is
treatable with the administration of DA agonists [15,16]. Several
common DA polymorphisms have been identified as risk alleles for
this disorder, including the dopamine transporter gene DAT1
[17,18], dopamine receptor genes [19], in particular DRD4 [20],
catechol-o-methyl transferase (COMT) [21], which participates in
the methylation and degradation of DA [22] and dopamine beta
hydroxylase (DBH) [23], which converts dopamine to norepi-
nephrine. The TaqIA polymorphism of another DA receptor,
DRD2, has also been implicated in sustained attention deficits
[24]. Behavioral genetics studies of these alleles suggest that they
affect dopaminergic ‘‘tone’’ [25], which in turn moderates the
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from neuroimaging studies of vigilance and sustained attention
lend further credence to this theory, as certain brain regions that
distinguish between good and poor performers (e.g. the dorsolat-
eral prefrontal cortex) [11,26] are richly innervated by DA
neurons [27].
In populations with ADHD, all of the alleles listed above (with
the exception of the DRD2 TaqI polymorphism) have been linked
to cognitive outcomes, in particular measures of executive
attention such as response inhibition [20,28–31]. The balance of
evidence in this literature suggests that individuals with greater
dopaminergic activity (e.g. through increased receptor binding
affinity or reduced enzymatic activity) tend to have better cognitive
performance, as measured by global task variables (i.e. accuracy/
reaction time). In contrast, the genetic correlates of individual
differences in attention in non-clinical populations are relatively
poorly understood [12]. Some studies in healthy populations have
replicated the findings cited above, showing, for example, that the
COMT Met allele is associated with better executive control [32],
though effects in the reverse direction have also been found [33].
Aside from the paucity of data on healthy individuals, studies of
the effects of dopamine on cognition have focused largely on
global variables, and have not examined the degradation of
performance over time. As slope variables may measure a different
facet of brain function than global variables, two competing
hypotheses present themselves. Maintaining a steady level of
functioning may depend on adequate dopamine signaling during
the period of task performance in much the same way this benefits
global outcomes. If so, we would expect individuals with alleles
promoting higher levels of dopamine to show reduced TOT
effects. Alternatively, TOT declines may be more greatly affected
by efficient baseline levels of functioning, as suggested by previous
fMRI data [11], in which case individuals with less dopaminergic
activity may show less performance degradation. Our primary aim
in this study, therefore, was to test these two hypotheses in order to
determine the effects of dopaminergic polymorphisms on objective
time-on-task decline as well as changes in subjective states in
healthy individuals.
Materials and Methods
Ethics statement
This study was approved by the Institutional Review Board of
the National University of Singapore, and all subjects provided
written informed consent before participating in the study.
Study procedure
A sample of N=350 undergraduates, graduate students and
staff members from the National University of Singapore were
recruited through online advertising and word-of mouth. Subjects
were pre-screened via a short telephone interview to ensure that
they met all inclusion criteria. To qualify for the study, participants
needed to be between 18 and 35 years of age, and ethnically Han
Chinese. This latter criterion was chosen to decrease the possibility
of artifacts owing to ethnic stratification, as Singapore is a racially
diverse immigrant society. We excluded subjects who admitted to
chronic physical or mental illness, had been diagnosed with a sleep
disorder, or who were taking long-term medication. Subjects were
also instructed to obtain a full night (.7 hours) of sleep for the 2
nights prior to the study, and to refrain from caffeine and alcohol
for 6 hours prior to coming into the lab. All testing took place in
the Cognitive Science Laboratory of Temasek Laboratories,
Singapore.
On entering the lab, subjects first provided self-reports of their
sleep history and alcohol/medication use over the previous
48 hours. They then provided self-ratings of several subjective
states (fatigue, stress, anxiety, depression, sleepiness, motivation
and energy) on a 9-point Likert-type scale. All questions took the
form ‘‘How fatigued/sleepy/anxious etc. do you feel?’’ Following
this, subjects were asked to remove their wristwatches and turn
off their cell phones. They were then given instructions for
performing the Psychomotor Vigilance Test (PVT) [34], and were
provided an opportunity to practice the test for one minute. The
practice period was kept relatively short to minimize pre-task
fatigue, and as the PVT is known to have minimal practice effects
[35]. After the practice, subjects were informed that they would
have to complete a 20-minute version of the test [36], and that
they should respond as quickly and accurately at all times to the
stimuli even if they were feeling bored or tired. Subjects then
performed the 20-minute PVT. To encourage subjects to exert
maximum effort during the test, a research assistant was seated
silently behind the participant at all times, as per standard test
procedure. On completing the test, subjects immediately rated
their subjective states again before completing the Pittsburgh Sleep
Quality Inventory (PSQI) [37] and several other personality
questionnaires. Personality data are not reported in this article.
Finally, subjects donated genetic material via a saliva sample using
the Oragene OG-500 collection kit (DNA Genotek, Ontario,
Canada).
To check on the test-retest reliability of the PVT, a subset
(N=56) of participants returned to the lab one week after their
initial session to complete the PVT a second time. Sleep history,
caffeine and substance use were similarly controlled for this
session.
Subjects were reimbursed $15 for their participation in the
experiment ($25 for subjects who visited the lab twice).
Behavioral data
The Psychomotor Vigilance Test (PVT) is a test of simple
reaction time that is mentally demanding because of its high
stimulus-load. The standard version of the test is 10 minutes in
length; however, in order to elicit greater TOT effects, a 20-
minute version was administered in this experiment. The
Windows PennPVT (Pulsar Informatics, Philadelphia, PA) was
used for stimulus presentation. During the test, subjects are
required to monitor a small box subtending approximately 4.1
(width)61.2 degrees (height) of visual angle for the appearance of a
millisecond counter, whereupon they respond with a button press
on the keyboard (space bar) as quickly as they can. The inter-
stimulus interval of this counter lasts from 2 to 10 seconds
(mean=6 s), and RTs are uniformly distributed across this range
of ISIs. Subjects are given 1 s after the counter stops to read their
reaction time. Further details of the PVT and its psychometric
properties can be found in references [36] and [38]. From each
individual 20-minute bout, we measured the TOT effect using
three different parameters. First, we extracted the linear slope of
the reciprocal of reaction times (RRT). Additionally, we measured
two parameters based on a least-squares fit to a two-component
exponential function [39], which has been found to account for
more of the variance in TOT than a simple linear fit. The
equation used was:
Predicted RT~A   1{e{T1 t 
z 1{
1
1ze{T2 t ðÞ
 
ð1Þ
where A is a multiplicative constant and t is time from test onset.
Raw reaction times were averaged into one-minute bins prior to
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dependent variables for subsequent analyses; these parameters
correspond respectively to a fast and slow decay in task
performance.
Genotyping methods
DNA was extracted from saliva samples, which were collected
with Oragene DNA OG-500 tubes (DNA Genotek Inc., Ontario
Canada) according to the manufacturer’s protocol. Single
nucleotide polymorphisms (SNPs) were analyzed by Sequenome
MassArray genotyping; this analysis was performed at the
Analytical Genetics Technology Centre, Princess Margaret
Hospital, Toronto, Canada. The variable number of tandem
repeats (VNTR) marker in the DAT gene was analyzed by PCR
with ReddyMix
TM PCR Master Mix (Thermo Scientific, Wal-
tham, MA, USA). Primer sequences were: forward 59-TGTG-
GTGTAGGGAACGGCCTG-39, reverse 59-CTTCCTGGAG-
GTCACGGCTCA-39. Thermal protocol included activation step
–9 4 uC for 5 min; 35 cycles of 94uC for 30 s, 55uC for 30 s, 72uC
for 90 s; and final hold at 72uC for 5 min. The exon III DRD4
48 bp VNTR was analyzed by PCR with HotStar Plus DNA
polymerase and Q-solution (Qiagen, Hilden, Germany). Primer
sequences were: forward 59- GCGACTACGTGGTCTACTCG -
39, reverse 59- AGGACCCTCATGGCCTTG -39. Thermal
protocol included activation step – 95uC for 15 min; 40 cycles of
94uC for 30 s, 55uC for 30 s, 72uC for 40 s; and final hold at 72uC
for 5 min. For both VNTR markers PCR products were visualized
with electrophoresis in 1.5% agarose gel. The four SNPs analyzed
were COMT Val158Met (rs4680), DBH Taq I (rs2519152),
DRD2 Taq1A (rs1800497) and DRD4 -521C/T (rs1800955).
Statistical analysis
Data analysis was performed using SPSS for Windows, Version
17.0 and MATLAB R2011B. Bivariate associations between
objective and subjective data were assessed using Pearson’s
correlations. To reduce the possibility of Type I error in analyzing
the genetic data, we restricted our search to six dopaminergic
alleles, consisting of two VNTRs and four SNPs. We created two
groups from each gene as follows: dopamine transporter gene
(DAT1) VNTR (10/10 vs. 10/9, 9/9, 11/10 and other rare
variants), DRD4 VNTR (2/2 and 2/4 vs. 4/4 and other rare
variants), dopamine receptor genes DRD4 -521C/T (T/T vs. C/
T and C/C), DRD2 TaqIA (any A1 allele vs. A2/A2), DBH Taq I
(A/A vs. A/G and G/G) and COMT Val/Met (Val/Val vs. Val/
Met and Met/Met). Overall univariate analysis of covariance
(ANCOVA) was performed using, in turn, the three TOT
measures (RRT slope, T1 and T2) as dependent variables, allele
subgroups as between-subjects fixed factors, and subjective change
in energy as a covariate. A separate ANCOVA was conducted
using subjective change in energy as the dependent variable, allele
subgroups as between-subjects fixed factors, and RRT slope as a
covariate.
Results
Behavioral results
Data from 18 participants were excluded for the following
reasons: not complying with instructions to obtain sufficient sleep
(n=11) and suspected non-compliance to task instructions (lapses
and/or false alarms .20; n=7). Examination of the PSQI
revealed that a substantial number of individuals reported habitual
poor sleep (PSQI.5; n=72) as defined by the standards of Buysse
et al. [37]. However, we found no correlation between PSQI
scores and RRT slope, suggesting that this variable was not a
confound in our results, and thus did not exclude subjects based on
high PSQI scores. No subject had a PSQI score higher than 10.
Our sample size after exclusions was therefore 332 (male=172;
mean age [SD]=21.7 (1.7))
Overall, subjects performed the PVT well, as indicated by the
low number of lapses (mean [SD]=2.59 (3.28)) and false alarms
(mean [SD]=1.59 (2.17)). The average median response time over
the entire sample was 264.3 ms (SD=26.2). Inspection of the
RRT slope showed that there was a decline in performance on
average over the 20-minute period (mean [SD]=20.026 (0.020)),
as well as a substantial amount of interindividual variation around
that mean (min=0.0312; max=20.089). More intuitively, raw
reaction times were, on average, 14.2% slower during the last
compared to the first four minutes of the task, with the worst
performer showing a 101.4% increase, and the best a 12.9%
decrease. Interestingly, and in agreement with previous studies of
this phenomenon, 28 out of 332, or 8.4% of participants
showed either no vigilance decrement, or a slight improvement
in performance over time.
We measured the stability of the time-on-task effect by inviting a
subset of participants (n=56) to undergo an identical second
session of testing. Intra-class correlation coefficients were comput-
ed on these results to assess the test-retest reliability of TOT
vulnerability. Between session (trait-like) reliability was significant,
but moderate (ICC1,1=.54, p,.01) A scatter plot of this
correlation is shown in Figure 1.
In addition to the RRT slope, we obtained parameters T1 and
T2 using the exponential fit in equation 1. While T2 was normally
distributed, T1 showed a bimodal distribution, thus necessitating
the use of bootstrapping in order to compare between-group
means. We created a bootstrapped distribution using 10,000 draws
from our original dataset, and calculated the difference of the
adjusted means (accounting for subjective energy change) of T1
between each allele group to obtain an estimated p-value for each
of these genes. Comparison of these p-values with those obtained
from the straightforward ANCOVA revealed that they are
extremely similar; we thus report results from the ANCOVA for
simplicity.
Subjective variables
In our main sample, performing the PVT resulted in significant
changes in all subjective variables, with the largest differences in
fatigue, sleepiness and energy (Table 1). Having made this
observation, we aimed to reduce the dimensionality of these data
by taking the difference between subjects’ pre-task and post-task
ratings, and subjecting these to factor analysis using a varimax
rotation. Results of this analysis are reported in Table 2. Two
components were found with eigenvalues of greater than 1
(Component 1: 2.307, 32.96% of variance; component 2: 1.522,
21.75% of variance). Fatigue and sleepiness loaded positively onto
component 1, and motivation and energy loaded negatively onto
this component. Stress, anxiety and depression loaded onto
component 2. These factors may therefore be interpreted
respectively as subjective change in energy (factor 1) and change
in mood (factor 2). We created two composite indices of these
factors by summing the relevant variables weighted by their
respective factor loadings. Reliability for these scales for subjects
who participated in two sessions was .52 (p,.01) and .54 (p,.01)
respectively. These indices were used for all further statistical tests.
We performed bivariate correlations to determine the relation-
ship between objective performance declines and subjective
mental states. RRT slope was correlated with the weighted index
of subjective changes in energy (r=2.22, p,.001) but not changes
in mood (r=2.033, n.s.). As a result, we chose to control for RRT
Dopamine Time-on-Task
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in energy, and vice versa.
Genetic data
Allele frequencies are presented in Table 3. We note that for the
DRD4 VNTR, the 7-repeat allele, which is relatively common in
Caucasian populations, is nearly absent among Han Chinese;
instead, the 2-repeat allele is present in this population at
approximately the same frequency. All candidate genes were
found to be in Hardy-Weinberg equilibrium at p..05.
We first examined the genetic data using a univariate approach
to determine which of our key outcome variables differed
depending on genotype group. These outcome variables were
RRT slope and the indices for subjective change in energy and
mood. None of the covariate by group interactions was significant
at the p,.05 level. Means and group sizes for each allele group are
shown in Table S1. After controlling for subjective change in
energy, we found that the omnibus test was significant for RRT
slope (F7,308=4.93, p,.001) and T2 (F7,308=, p=.001), but not
T1. In the analysis of the linear RRT slope, DAT1 VNTR
(F1,325=4.59, p,.05) and COMT Val/Met (F1,325=5.01, p,.05)
polymorphisms were significantly associated with time-on-task
declines (Table 4; Figure 2). In both these cases, genotypes thought
to result in greater dopaminergic tone (the 10-repeat present group
for DAT1 and the Met-allele absent group for COMT) were
associated with steeper declines in performance over time. Effect
sizes (partial g
2) for these alleles were in the small-medium range
(.015 and .016 respectively). The difference between allele groups
for DRD4 approached significance (F1,325=3.87, p=.051) Using
the parameters from the exponential fit, we found that DAT1 and
COMT were associated with the slow decay parameter (T2) but
not the fast decay (T1) (Table 5). To better visualize this difference,
we plotted average curves for each allele group using the estimated
subject parameters; these are displayed for comparison in Figure 3.
Figure 1. Inter-session reliability of time-on-task slope. Time-on-task slope is significantly correlated across two test sessions spaced one week
apart (ICC1,1=.54, p,.01). Subjects show a tendency to perform slightly worse in the second session.
doi:10.1371/journal.pone.0033767.g001
Table 1. Paired t-tests comparing subjective states before and after PVT performance.
Subjective variable Pre-test average [SD] Post-test average [SD] t-value (t330) Pre-post task correlation (r)
Fatigue 3.39 (2.07) 5.54 (2.13) 218.82‘ .561
Stress 3.54 (1.76) 3.87 (1.71) 24.26 .684
Anxiety 2.97 (1.60) 3.26 (1.69) 23.97 .674
Sleepiness 3.28 (1.51) 4.99 (1.80) 219.78 .564
Depression 2.18 (1.29) 2.52 (1.51) 26.40 .778
Motivation 4.95 (1.40) 4.39 (1.34) 8.25 .624
Energy 5.28 (1.17) 4.17 (1.34) 17.94 .611
‘degrees of freedom=311 due to missing data.
All t and r values significant at p,.001.
doi:10.1371/journal.pone.0033767.t001
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further probe the effect of these alleles on other common PVT
parameters. Accordingly, we extracted the number of lapses
(responses.500 ms) and false alarms, and computed a metric of
attentional stability [40], the intra-individual coefficient of
variation (ICV), by dividing the SD of reaction times by the mean
[41]. As the distribution of ICV showed significant skewness, we
normalized it by taking its inverse before performing further
statistical tests on this variable. RRT slope was significantly
correlated with lapses (r=2.71, p,.001), false alarms (r=2.33,
p,.001) and ICV (r=2.39, p,.001). After controlling for
subjective change in energy, we found no differences between
genotype groups in either DAT1 or COMT in any of these
variables.
When confronted with a vigilance task, it is possible that subjects
may withhold effort at the beginning of the trial so as to conserve
resources, and thus better maintain performance. As part of the
study setup, we took steps to mitigate this issue by instructing
participants to exert maximum effort at all times, and by having an
experimenter observe the subject throughout the study. We
checked on this potential confound by correlating RRT slope
with mean reaction time from the first minute of the PVT, and
found a small but significant positive correlation between them
(r=.13, p,.05). Having discovered this, we again looked for
differences in genotype group based on this dependent variable,
but found no differences in DAT1 or COMT. Furthermore,
adding this variable as a covariate to the ANCOVAs reported
above does not materially change our main results. Thus, the
genetic differences observed seem to be exclusively related to TOT
performance decrements.
For the subjective data, the overall effect of the six dopamine
polymorphisms was also significant (F7,308=3.43, p=.002);
however, only the DRD4 VNTR (F1,325=13.71, p,.001,
g
2=.044) was significantly related to changes in energy across
the duration of the task (Table 6; Figure 4) after controlling for
RRT slope. No significant associations were found between any of
our candidate genes and subjective changes in mood.
Discussion
The results of this study demonstrate links between several
functional dopaminergic alleles and the propensity to both decline
in performance and feel mentally fatigued. Specifically, our data
suggest that the dopamine transporter, DAT1, as well as COMT,
may have an impact on the rate at which the vigilance decrement
occurs, and that the dopamine receptor DRD4 may be related to
subjective declines in mental energy. This is one of the first
demonstrations that these polymorphisms play such a role in
attention in non-clinical populations.
For the two genes that were associated with TOT, alleles that
typically confer risk of poorer cognitive performance (i.e. the Val/
Val allele [21,42] and the 10-repeat allele of the DAT1 VNTR
[17,18,28]) were protective against TOT declines in our sample,
although selective studies on healthy populations have also found
Table 2. Factor analysis (with varimax rotation) of the change
in subjective variables from pre- to post-task.
Variable Factor 1 (subjective energy) Factor 2 (mood)
Fatigue .659 .112
Stress .092 .843
Anxiety 2.033 .883
Sleepiness .689 .136
Depression .191 .557
Motivation 2.702 .016
Energy 2.733 2.101
Bold values indicate factor loaded on to by each variable.
doi:10.1371/journal.pone.0033767.t002
Table 3. Allele counts and frequencies.
Genetic
polymorphism Genotype Allele frequencies
Hardy-
Weinberg
equilibrium
DAT1 VNTR 9/9 9/10 9/11 10-repeat 9-repeat 11-repeat Others Yes (p=.91)
1 (0.3%) 40 (12.1%) 0 (0.0%) 631 (91.2%) 42 (6.1%) 14 (2.0%) 5 (0.7%)
10/10 10/11 11/11
287 (87.0%) 12 (3.6%) 1 (0.3%)
DRD4 VNTR 2/2 2/4 2/5 4-repeat 2-repeat 5-repeat Others Yes (p=.11)
12 (3.8%) 89 (27.9%) 5 (1.6%) 519 (74.8%) 140 (20.2%) 14 (2.0%) 21 (3.0%)
4/4 4/5 5/5
206 (64.6%) 6 (1.8%) 1 (0.3%)
DRD4 -521C/T T/T T/C C/C T allele C allele Yes (p=.09)
150 (45.2%) 131 (39.5%) 48 (14.5%) 431 (67.0%) 227 (33.0%)
DRD2 TaqIA T/T T/C C/C T allele C allele Yes (p=.99)
112 (33.7%) 158 (47.6%) 55 (16.6%) 382 (58.8%) 268 (41.2%)
COMT Val/Met G/G G/A A/A G allele A allele Yes (p=.99)
183 (55.1%) 121 (36.4%) 20 (6.0%) 487 (75.2%) 161 (24.8%)
DBH TaqI A/A A/G G/G A allele G allele Yes (p=.63)
247 (74.4%) 70 (21.1%) 3 (0.9%) 566 (88.2%) 76 (11.8%)
doi:10.1371/journal.pone.0033767.t003
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in question are thought to increase the availability of DA to post-
synaptic neurons, thus promoting activity in striatal and prefrontal
regions implicated in stable attentional performance. Thus, our
results argue against the hypothesis that global variables such as
mean reaction time and the slope variable of time-on-task are
affected in the same way by dopaminergic activity
The direction of the dopamine effect in this study may be best
explained by the tonic-phasic model of dopamine regulation. In a
seminal set of papers, Grace and colleagues [25,44] described this
dissociation, and showed that dopamine exerts an influence on
post-synaptic activity via two separate but related mechanisms.
First, phasic DA release is triggered when bursts of action
potentials are fired in response to environmental stimuli and reach
DA axon terminals [45]. This release leads to a large and rapid
rise in intrasynaptic dopamine; however, this rise is also highly
transient due to the immediate action of the DA transporter,
which causes reuptake of DA into pre-synaptic terminals [46]. In
contrast, tonic DA activity refers to spontaneously occurring single
spikes in DA neurons [47] which determine the baseline levels of
DA concentration in extracellular space [48].
In the long-term, the tonic and phasic DA systems are not
independent. For instance, stimulants such as cocaine block
reuptake of DA from the synaptic cleft [49], allowing increased
leakage of DA into extracellular space. Abusers of these stimulants
tend to have an increase in tonic DA activity, and a subsequent
down-regulation of the post-synaptic DA system over time (for a
comprehensive review, see [23]). Furthermore, it has been
demonstrated that individuals with relatively low dopaminergic
tone also have larger phasic release of DA in response to an
external stimulus (e.g. nicotine) [50]. These results may have
implications for cognitive functioning; for instance, a model of
dopamine function in PFC has shown that tonic and phasic
evels of DA interact to determine optimal performance on a
Table 4. Univariate ANCOVA of the effects of dopamine alleles on RRT slope.
Source Type III SS df Mean square F Significance Partial g
2
Full model 0.013 7 0.002 4.93 ,.001 .103
Intercept 0.029 1 8610
26 76.67 ,.001 .203
Factors
DRD4 VNTR 0.001 1 0.001 3.87 .051 .013
DAT1 VNTR 0.002 1 0.002 4.59 .033 .015
DRD4 -521 C/T 0.001 1 0.001 1.64 .201 .005
DRD2 Taq1A 0.000 1 0.000 1.07 .302 .004
COMT Val/Met 0.002 1 0.002 5.01 .026 .016
DBH TaqI 8.5610
25 18 . 5 610
25 0.22 .684 .001
Covariate
Subjective change in energy 0.008 1 0.008 21.5 ,.001 .067
Values in bold text are significant at p,.05.
doi:10.1371/journal.pone.0033767.t004
Figure 2. Average time-on-task slope by allele group. Means and standard errors for reciprocal reaction time slope in each allele group. *
represents p,.05. Yellow bars represent allele groups thought to have greater dopamine availability.
doi:10.1371/journal.pone.0033767.g002
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(tonic) DA activity is low [51].
As mentioned previously, alleles associated with greater DA
availability are usually found to be of benefit in a range of
cognitive tasks. However, our data suggest that slope variables may
be affected much more greatly by DA tone than phasic DA
release, thus explaining the inferior performance of individuals
with DA-promoting alleles. Differences between DAT1 and
COMT genotype groups in this sample were found only for
TOT variables, and not lapses, false alarms or reaction time
variability, despite the fact that these variables are highly inter-
correlated. We also found evidence that some subjects were able to
ameliorate their level of TOT decline by withholding effort
(possibly unconsciously), as mean first-minute reaction times were
positively correlated with RRT slope. Nevertheless, DAT1 and
COMT genotype groups did not differentiate performers on this
variable either. We therefore speculate that individuals with
chronically high DA availability may more quickly exhaust the
benefits of greater phasic release when longer-term attentional
effort is required, due to the long-term plastic changes in DA
neurons in the striatum and PFC described above. These effects
may be especially prominent when elicited by the PVT, which is a
task with consistently high signal load and attentional demand.
The assertion that tonic, resting levels of DA may influence
TOT changes is consistent with data from a recent study in which
Lim et al. [11] used fMRI to measure the baseline and task-related
activity of a group of young subjects as they performed the
Psychomotor Vigilance Task (PVT). The authors found that
Table 5. Univariate ANCOVA of the effects of dopamine alleles on exponential time-on-task parameters.
T1 T2
Source Type III SS df
Mean
square F Significance Partial g
2 Type III SS df
Mean
square F Significance Partial g
2
Full model 2990.1 7 427.2 1.32 .211 .028 0.086 7 0.012 3.31 .001 .077
Intercept 22722.4 1 22722.4 66.61 ,.001 .181 0.159 1 0.159 46.28 ,.001 .133
Factors
DRD4 VNTR 365.2 1 365.2 1.07 .302 .004 0.007 1 0.007 2.27 .151 .007
DAT1 VNTR 70.1 1 70.1 0.11 .651 .001 0.020 1 0.020 6.36 .017 .019
DRD4 -521 C/T 59.6 1 59.6 0.28 .676 .001 0.006 1 0.006 2.18 .185 .006
DRD2 Taq1A 38.1 1 38.1 0.06 .739 .000 0.002 1 0.002 0.78 .400 .002
COMT Val/Met 704.5 1 704.5 2.15 .152 .007 0.018 1 0.018 5.17 .024 .017
DBH TaqI 0.1 1 0.1 0.01 .984 .000 0.008 1 0.008 2.36 .131 .008
Covariate
Subjective change
in energy
1401.2 1 1401.2 4.78 .044 .013 0.031 1 0.031 9.82 .002 .029
Values in bold text are significant at p,.05. As T1 was not normally distributed, we calculated t-values for between-group comparisons on adjusted means for this
variable using a bootstrapping method (see text for details); as these results were highly similar to the ANCOVA results, the latter are reported here for simplicity.
doi:10.1371/journal.pone.0033767.t005
Figure 3. Average reaction time curves by allele group for DAT1 and COMT. Curves were plotted using predicted values calculated from
average parameters A, T1 and T2 for each allele group. The thinner dotted curves represent the mean 6 one standard error. Note that the curvature of
the trends is only slight despite the use of an exponential equation; this is due to the bimodality of T1, for which large values cause the curve to
approach linearity. Panel A: COMT allele groups. Panel B: DAT1 allele groups.
doi:10.1371/journal.pone.0033767.g003
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frontal gyrus (MFG) predicted the extent of subsequent perfor-
mance decline, with higher MFG activity at rest correlated with
greater TOT decrements. Taken together with our current genetic
data, we speculate that this higher MFG resting perfusion may be
related to greater spontaneous firing rates which result from higher
DA tone. Indeed, negative correlations have been found between
striatal DAT density and regional cerebral blood flow in frontal
cortex [52], providing in vivo support for this claim. This view is
also consistent with the notion that fMRI activity may represent an
endophenotypic trait [53,54] that mediates between genetic
differences and behavioral phenotypes.
While both DAT1 and COMT were found to have an effect on
PVT performance in this study, presumably via the modulation of
levels of extracellular DA, we note that these molecules likely
influence this phenotype via different sites in the brain. COMT
acts to degrade DA primarily in PFC, with a ,40% difference in
enzyme activity between the Val and Met alleles [55]. Further-
more, COMT is significantly less active in the striatum than PFC,
as DA persists in extracellular space for a much longer time in the
PFC [56]. In contrast, the DA transporter has a much larger effect
on reuptake in the ventral striatum than in frontal cortex [57].
Hence, DAT1 may exert its influence on attention indirectly,
possibly by modulating levels of motivation during the task.
Further research is needed to test the more fine-grained effects of
these two polymorphisms on TOT decrements.
Fast vs. slow decay
By decomposing individual subject curves into two components
using a set of exponential functions, we found that DAT1 and
COMT polymorphisms were associated with differences in the
slow, but not the fast decaying component. Effect sizes of genotype
on the slow component were, in fact, slightly larger than for the
simple linear fit. These data suggest that dopamine exerts its effects
on longer-term TOT decay, which lends credence to the
hypothesis that the direction of the effects observed in this
experiment (i.e. COMTMet,COMTVal; DAT110-repeat absent,-
DAT1
10-repeat present) may only be observable when the dependent
measure is a slow-evolving process.
Subjective changes
As expected, performing the PVT for 20-minutes resulted not
only in robust TOT decrements, but also significant declines in
energy and mood. This is consistent with findings from previous
studies which suggest that vigilance tests are a resource-demanding
form of mental work [3,4]. A factor analysis showed that energy
and mood changes loaded onto separate scales, suggesting that
different biological pathways may underlie these subjective
changes. These factors correspond well with a two-system model
of activation (energetic and tense arousal) proposed by Thayer
[58], adding support for their validity. Moreover, in the current
dataset, we found that objective TOT declines were correlated
with changes in energy, but not mood, indicating that the former
scale more closely reflects the phenomenology associated with
mental workload.
Table 6. Univariate ANCOVA of the effects of dopamine
alleles on subjective change in energy.
Source Type III SS df
Mean
square F Significance Partial g
2
Full model 11.9 9 1.70 3.43 .002 .074
Intercept 48.2 1 48.2 97.37 ,.001 .244
Factors
DRD4 VNTR 6.78 1 6.78 13.71 ,.001 .044
DRD1 VNTR 0.12 1 0.12 0.24 .624 .001
DRD4 -521 C/T 0.01 1 0.01 0.01 .905 .000
DRD2 Taq1A 1.19 1 1.19 2.40 .122 .008
COMT Val/Met 0.17 1 0.17 0.33 .564 .001
DBH TaqI 0.15 1 0.15 0.30 .585 .001
Covariate
RRT slope 4.40 1 4.40 8.90 ,.003 .029
Values in bold text are significant at p,.05.
doi:10.1371/journal.pone.0033767.t006
Figure 4. Average subjective change in energy by allele group. Means and standard errors for average subjective energy change in each
allele group. * represents p,.05. Yellow bars represent allele groups thought to have greater dopamine availability.
doi:10.1371/journal.pone.0033767.g004
Dopamine Time-on-Task
PLoS ONE | www.plosone.org 8 March 2012 | Volume 7 | Issue 3 | e33767Interestingly, subjective changes in energy were strongly
associated with the DRD4 polymorphism; subjects with at least
one copy of the 2-repeat allele tended to show a greater subjective
change in energy over time. To our knowledge, this is the first
association of the allele with this effect, although previous work has
implicated DAT1, COMT and DRD2 in mental fatigue [59], and
the role of dopamine in maintaining an energetic state has been
extensively discussed [60]. Experimentally, catecholamine deple-
tion is known to decrease energy and vigor, and increase
sleepiness, fatigue and sedation [61]. Reproducing and explaining
the effect of DRD4 on subjective mental fatigue represents a
promising avenue for ameliorating this problem in real-world
situations.
Finally, significant increases in anxiety, stress and depression
represent a separate problem that is putatively caused by high
mental workload. Our data suggested that changes in mood are
not directly associated with TOT; nevertheless, they represent an
undesirable side effect that may lead to other negative conse-
quences. Further research is needed to characterize how these
changes are instantiated in the brain, and how they might affect
behavior and performance.
Limitations
The current study has a small number of limitations. First,
subjects were asked to abstain from caffeine, which may have
caused some regular users to experience a withdrawal effect.
However, data collected from other studies by the first author
indicate that caffeine usage in Singapore students is low, and we
thus suggest that any such effects were relatively minor. Second,
and more importantly, we note that our sample size was moderate
for a study of this nature, and that the effects observed were in the
small to medium range, exposing us to the possibility of Type I
error. Nevertheless, we count two points in our favor. First, we had
strong a priori justification based on the previous clinical literature
that the alleles under investigation are involved in sustained
attention, and tested only a small number of these candidate genes.
Second, more than one of the comparisons performed returned a
significant result in the same direction, and as these form part of a
single system, are unlikely when taken together to be spurious
findings.
We note that the reliability of the TOT effect, as is typical with
change scores, is only in the moderate range (.54), as are the intra-
class correlations of the subjective measures used in this paradigm.
This is not unexpected, as difference or slope scores by their nature
have lower reliability than measures of central tendency [62]. We
believe that the relatively lower reliability of change scores speaks
more to the method of their computation than against the trait-like
nature of TOT vulnerability; however, we recommend that large
sample sizes be used when studying this phenomenon in the future
to ensure that results are valid and reproducible.
Conclusion
An increasing amount of evidence points to TOT vulnerability
as being the result of the cortical attention system drawing on a
brain-limiting resource that is determined by resting levels of
neuronal activity. Our genetic data strengthen the case that one of
the resources in question may be dopamine, and that these
individual differences may be more highly related to tonic brain
functioning than phasic task-related activity. We further demon-
strate that TOT vulnerability is associated with changes in energy
but not mood, and that DRD4 is robustly related to the feelings of
energy depletion. The results of this study have implications for the
emerging field of neuroergonomics [63,64], and add to our
knowledge of the biological basis of mental ‘‘work’’ and its
fatiguing effects.
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